Good Biotech Integrated Snakebite Solution
Rapid POCT Kit & Superior IgY(ΔFc)-Derived Snake Antivenom Immunoglobulins for Precision Therapy
Overview
Good Biotech presents a groundbreaking integrated solution for snakebite envenoming—a world-first rapid point-of-care test (POCT) kit combined with next-generation IgY(ΔFc)-derived snake antivenom immunoglobulins. This precision therapy platform meets the urgent global need for safe, effective, and affordable snake antivenoms as called for by the WHO, setting a new benchmark in snakebite diagnosis and treatment.
Rapid Snake Venom POCT Kit
The World’s Only True POCT Kit for Snakebite Diagnosis
-
Rapid Identification:
A one-step visual test that detects snake venom within 3–5 minutes, providing immediate guidance for targeted treatment. -
Immediate Impact:
Enables healthcare professionals to quickly identify the specific snake species responsible for envenoming, ensuring that only the corresponding IgY(ΔFc)-Based Snake Antivenom Immunoglobulins are administered. This precision prevents the unnecessary use of multiple, non-specific antivenoms, minimizes adverse side effects, and conserves critical resources. -
Uniqueness:
As the only true POCT kit available globally, it revolutionizes snakebite diagnosis—especially in rural and resource-limited settings where timely intervention is critical.
IgY(ΔFc)-Based Snake Antivenom Immunoglobulins
Precision Therapy for Snakebite Envenoming
-
Comprehensive Coverage:
- Monospecific Antivenoms: Tailored for neurotoxic or hematotoxic bites.
- Polyspecific Antivenoms: Formulated for broader regional applications.
-
Superior Performance Over Classical Equine IgG-Based Antivenoms:
- Enhanced Neutralization: 10-20 times more effective per unit of antibody.
- Improved Productivity: Over 100 times more productive, enabling rapid generation of high-quality antibodies with faster immune response times.
- Enhanced Safety: Derived from egg yolk, these IgY(ΔFc) antibodies are completely free from allergic reactions, ensuring a safer treatment profile compared to traditional horse IgG-based antivenoms.
- Cost-Efficiency: A simple, animal-friendly extraction process substantially lowers production costs, ensuring affordability without compromising quality.
The Integrated Package
A Turnkey Precision Therapy Solution for the Global Snakebite Crisis
-
Seamless Integration:
Our rapid POCT kit and IgY(ΔFc)-Derived Snake Antivenom Immunoglobulins work synergistically to provide an immediate, species-specific treatment solution. This integrated package streamlines the process from diagnosis to therapy, ensuring that patients receive the precise antivenom they need. -
Global Impact:
This precision therapy solution directly addresses the WHO’s urgent call for improved snakebite management by offering a safe, effective, and affordable option—particularly critical in regions where snakebite envenoming is a major public health issue. -
Collaborative Opportunity:
We welcome collaboration with global partners to co-develop or pursue technology transfer opportunities that further expand and scale this mature technology, ensuring rapid deployment and widespread access to precision snakebite management.
Contact Us:
If you are interested in pursuing a co-development or a technology transfer opportunity, please contact our Partnering Team at partnership@good-biotech.com
Good Biotech’s integrated solution sets a new standard in snakebite management by combining the world’s only true POCT kit with superior IgY(ΔFc)-derived antivenoms—delivering precision therapy that saves lives and optimizes resource use worldwide.
